TY - JOUR
T1 - Current state and prospects of biotechnology in Central and Eastern European countries. Part I: Visegrad countries (CZ, H, PL, SK)
AU - Dettenhoffer, Markus
AU - Ondrejovic, Miroslav
AU - Vasary, Viktoria
AU - Kaszycki, Pawel
AU - Twardowski, Tomasz
AU - Stuchlik, Stanislav
AU - Turna, Jan
AU - Dundar, Munis
AU - Gartland, Kevan M.
AU - Miertus, Stanislav
N1 - Created as conf. paper, changed to article ET
Applied 'no exception' result (re author status). ET 25/10/19
PY - 2019/1/2
Y1 - 2019/1/2
N2 - Innovation is a key determinant of sustainable growth. Biotechnology (BT) is one such industry that has witnessed a revolution in innovative ideas leading to the founding of many new companies based on providing products, solutions and services, stretching from the food industry to environmental remediation, and new medicines. BT holds much promise for the development of national and local economies, however, this requires a strategic approach involving actors withingovernment, industry, and academia working in concert to maximize this potential. This first article reviews the current “state of play” in the field of BT within the Central Eastern European (CEE) countries. For the purposes of this article, CEE refers to the countries of Czech Republic, Hungary, Poland, and Slovakia (the so-called Visegrad – V4 countries). We examine the componentsthat support the creation and development of a BT sector in CEE and also highlight the barriers to these objectives. Clearly setting priorities for the countries’ policy agenda, as well as the alignment of Smart Specialization Strategy will help to focus efforts. Recent investments in R&D infrastructure within CEE have been substantial, but conditions will need to be optimized toharness these largely European investments for effective use towards SME high-tech development.
AB - Innovation is a key determinant of sustainable growth. Biotechnology (BT) is one such industry that has witnessed a revolution in innovative ideas leading to the founding of many new companies based on providing products, solutions and services, stretching from the food industry to environmental remediation, and new medicines. BT holds much promise for the development of national and local economies, however, this requires a strategic approach involving actors withingovernment, industry, and academia working in concert to maximize this potential. This first article reviews the current “state of play” in the field of BT within the Central Eastern European (CEE) countries. For the purposes of this article, CEE refers to the countries of Czech Republic, Hungary, Poland, and Slovakia (the so-called Visegrad – V4 countries). We examine the componentsthat support the creation and development of a BT sector in CEE and also highlight the barriers to these objectives. Clearly setting priorities for the countries’ policy agenda, as well as the alignment of Smart Specialization Strategy will help to focus efforts. Recent investments in R&D infrastructure within CEE have been substantial, but conditions will need to be optimized toharness these largely European investments for effective use towards SME high-tech development.
KW - Biotechnology (BT)
KW - Central Eastern Europe (CEE)
KW - Visegrad countries (V4)
KW - Smart Specialization Strategy (RIS3)
KW - higher education
KW - public financing science
KW - venture capital
U2 - 10.1080/07388551.2018.1523131
DO - 10.1080/07388551.2018.1523131
M3 - Article
VL - 39
SP - 114
EP - 136
JO - Critical Reviews in Biotechnology
JF - Critical Reviews in Biotechnology
SN - 0738-8551
IS - 1
ER -